Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
Hezbollah has suffered a string of military defeats by Israel, culminating in the assassination of its leader Hassan Nasrallah in…
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
NAPOLI (ITALPRESS) – Quarta vittoria stagionale per il Napoli. Il 2-0 rifilato al Monza regala agli uomini di Antonio Conte…
EMPOLI (ITALPRESS) – Empoli e Fiorentina danno vita a una partita poco entusiasmante e chiudono il derby toscano con un…
PALERMO (ITALPRESS) – Gianluca Quondam Gregorio, cavaliere catanese della nazionale italiana, con un lungo e qualificato curriculum sportivo, ha iscritto…